Login / Signup

Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007-3015.

Ian J NeelandTakatoshi KasaiCatherine M ViscoliBrian S WojeckHenry K YaggiOdd Erik Johansennull null
Published in: Diabetes care (2021)
Keyphrases
  • obstructive sleep apnea
  • positive airway pressure
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • sleep apnea
  • open label
  • glycemic control
  • insulin resistance